Evidence map›Paper›PMID 40628501›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2025

Association of

Xiangli Yin, Quan Zhu, Ji Li, Yizhou Zou, Qizhi Luo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiangli YinDepartment of Immunology, Xiangya School of Basic Medical Sciences, Central South University, Changsha 410013. yinxiangli@csu.edu.cn.
Quan ZhuDepartment of Immunology, Xiangya School of Basic Medical Sciences, Central South University, Changsha 410013.
Ji LiDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China.
Yizhou ZouDepartment of Immunology, Xiangya School of Basic Medical Sciences, Central South University, Changsha 410013.
Qizhi LuoDepartment of Immunology, Xiangya School of Basic Medical Sciences, Central South University, Changsha 410013. Luoqz1025@163.com.

Funding

the "13th Five-Year Project" of Hunan Provincial Education Science ND206997the Hunan Provincial Natural Science Foundation 2020JJ4768
6 · The paper itself

Abstract

objectivesThe major histocompatibility complex class I chain-related gene A (

methodsPeripheral blood DNA samples were collected from 84 patients with rosacea (rosacea group) and 223 healthy volunteers (control group) who visited the Dermatology Outpatient Department of Xiangya Hospital of Central South University between November 2017 and November 2019.

resultsBlood tests in rosacea patients showed mildly elevated, with no significant changes in lymphocyte counts. Both PCR-SBT and NGS accurately identified

conclusions

Indexed as

Genetic Predisposition to DiseaseHistocompatibility Antigens Class IPolymorphism, Single NucleotideRosaceaAdultAgedAllelesCase-Control StudiesFemaleGene FrequencyGenotypeHaplotypesHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedHistocompatibility Antigens Class IMHC class I-related chain Aallelegene polymorphismshuman leukocyte antigenmajor histocompatibility complex class I chain-related gene Apolymerase chain reaction-sequencing-based typingrosaceashort tandem repeatssingle nacleotide polymorphismthe next-generation sequencing

Identifiers

PMID40628501
PMCPMC13345771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.